Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoarthritis in 2007.

Svetlana Krasnokutsky1, Jonathan Samuels, Steven B Abramson

  • 1New York University School of Medicine, Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY 10003, USA.

Bulletin of the NYU Hospital for Joint Diseases
|October 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Knee Osteoarthritis Detection by Multi-Component T<sub>2</sub> Mapping.

Bioengineering (Basel, Switzerland)·2026
Same author

Adiabatic Pulse Shape Influence on the Orientation Dependence of T<sub>1ρ</sub> Relaxation.

Magnetic resonance in medicine·2026
Same author

Potential Predictors of Pain and Stiffness Response Following Genicular Artery Embolization for Knee Osteoarthritis.

Journal of clinical medicine·2026
Same author

Detection of Early Knee Osteoarthritis Using Multi-Component T<sub>1ρ</sub> Mapping.

Journal of magnetic resonance imaging : JMRI·2025
Same author

A double-blind, placebo-controlled, multi-crossover trial of treatment with a chemokine antagonist for knee osteoarthritis pain.

Pain·2025
Same author

Patterns of Shared Variation in Knee Ultrasound for Osteoarthritis: A Machine Learning Approach.

Osteoarthritis imaging·2025
Same journal

Mosaicplasty for the treatment of the osteochondral lesion in the femoral head.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Hibernoma--a case series with multimodality imaging and pathologic correlation.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Progressive migration of broken Kirschner wire into the proximal tibia following tension-band wiring technique of a patellar fracture--case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Multidrug-resistant Acinetobacter baumannii infection following para-articular steroid injection in the knee--a case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Extensor indicis proprius and extensor digitorum communis rupture after volar locked plating of the distal radius--a case report.

Bulletin of the NYU hospital for joint diseases·2012
Same journal

Bilateral four-part anterior fracture dislocation of the shoulder--a case report and review of literature.

Bulletin of the NYU hospital for joint diseases·2012
See all related articles

Osteoarthritis (OA) is a disabling joint disease. This review details OA

Area of Science:

  • Orthopedics
  • Rheumatology
  • Molecular Biology

Background:

  • Osteoarthritis (OA) is a progressive, disabling joint disease influenced by age, genetics, trauma, and knee alignment.
  • Pathophysiological mechanisms involve synovium, bone, and cartilage, leading to joint degeneration.
  • Developing disease-modifying osteoarthritis drugs (DMOADs) has been challenging due to complex disease mechanisms.

Purpose of the Study:

  • To review current pathological mechanisms in OA joint compartments.
  • To discuss therapeutic interventions for OA.
  • To highlight the role of biomarkers in DMOAD development.

Main Methods:

  • Literature review of current OA research.
  • Analysis of pathophysiological mechanisms in OA.

Related Experiment Videos

  • Summary of existing and emerging OA therapies.

    • Main Results:

    • OA involves complex molecular and physiological processes across joint tissues.
    • Biomarker validation is crucial for advancing DMOAD development.
    • Therapeutic strategies target interconnected pathological pathways.

    Conclusions:

    • Understanding OA's multi-compartment pathology is key for effective treatment.
    • Biomarkers are essential for the future development of DMOADs.
    • A combination of therapeutic approaches may be necessary for managing OA.